SCHEMBL24095490

SCHEMBL24095490

O=C1CO[C@H]2CCN(C(=O)N3CCC(Cc4ccc(F)cc4Cl)CC3)C[C@H]2N1

nearest known ligand 0.59

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 10/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25785256 1.00 MGLL (0.59) MGLL
SCHEMBL25785733 0.91 MGLL (0.62) MGLL
SCHEMBL24095478 0.91 MGLL (0.62) MGLL
SCHEMBL23181588 0.91 MGLL (0.62) MGLL
SCHEMBL23176622 0.91 MGLL (0.62) MGLL
SCHEMBL23850057 0.90 MGLL (0.52) MGLL
SCHEMBL21730857 0.89 MGLL (0.75) MGLL
SCHEMBL24095425 0.88 MGLL (0.54) MGLL
SCHEMBL23148861 0.87 MGLL (0.61) MGLL
SCHEMBL21734202 0.85 MGLL (0.80) MGLL

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20210387999-A1 HETEROCYCLIC COMPOUNDS HOFFMANN-LA ROCHE INC. (US) 2021-12-16 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20210387999-A1 HETEROCYCLIC COMPOUNDS CYP1B1, CYP4B1, CYP4X1 MGLL 1712/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback